These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL. J Biol Chem; 1988 Apr 15; 263(11):5183-9. PubMed ID: 3128537 [Abstract] [Full Text] [Related]
17. Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system. Koizumi J, Inazu A, Fujita H, Takeda M, Uno Y, Kajinami K, Mabuchi H, Takeda R. Atherosclerosis; 1988 Nov 24; 74(1-2):1-8. PubMed ID: 3145747 [Abstract] [Full Text] [Related]
18. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V. Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028 [Abstract] [Full Text] [Related]